Stair climbing and the incidence of atherosclerotic cardiovascular disease: a population-based prospective cohort study.


Journal

Environmental health and preventive medicine
ISSN: 1347-4715
Titre abrégé: Environ Health Prev Med
Pays: Japan
ID NLM: 9609642

Informations de publication

Date de publication:
2023
Historique:
medline: 31 10 2023
pubmed: 30 10 2023
entrez: 29 10 2023
Statut: ppublish

Résumé

Stair climbing is a readily available form of physical activity with potential cardioprotective merits. Herein, we investigated the association between stair climbing and atherosclerotic cardiovascular disease (ASCVD) incidence among Japanese people. This prospective cohort study used data from 7,282 participants, aged 30-84 years, registered in the Suita Study and free from stroke and ischemic heart disease (IHD). Standard approaches were used to detect incident ASCVD events, including cerebral infarction and IHD, during follow-up. Stair climbing was assessed using a baseline questionnaire. We applied the Cox regression to calculate the hazard ratios (HRs) and 95% confidence intervals (95% CIs) of incident ASCVD for climbing stairs in 20-39%, 40-59%, and ≥60% compared to <20% of the time. We adjusted the regression models for age, sex, body mass index, smoking, alcohol consumption, physical activity, hypertension, diabetes, atrial fibrillation, lipid profile, chronic kidney disease, and history of cardiac murmur or valvular diseases. A total of 536 new ASCVD events were detected within a median follow-up period of 16.6 years. In the age- and sex-adjusted model, stair climbing 20-39%, 40-59%, and ≥60% of the time was associated with lower ASCVD incidence: HRs (95% CIs) = 0.72 (0.56, 0.92), 0.86 (0.68, 1.08), and 0.78 (0.61, 0.99), respectively (p-trend = 0.020). The corresponding associations were attenuated after adjusting for lifestyle and clinical factors: HRs (95% CIs) = 0.74 (0.58, 0.95), 0.90 (0.71, 1.13), and 0.89 (0.69, 1.13), respectively (p-trend = 0.152). Frequent stair climbing was associated with lower ASCVD incidence; however, this association was partly explained by lifestyle and clinical factors of participants.

Sections du résumé

BACKGROUND BACKGROUND
Stair climbing is a readily available form of physical activity with potential cardioprotective merits. Herein, we investigated the association between stair climbing and atherosclerotic cardiovascular disease (ASCVD) incidence among Japanese people.
METHODS METHODS
This prospective cohort study used data from 7,282 participants, aged 30-84 years, registered in the Suita Study and free from stroke and ischemic heart disease (IHD). Standard approaches were used to detect incident ASCVD events, including cerebral infarction and IHD, during follow-up. Stair climbing was assessed using a baseline questionnaire. We applied the Cox regression to calculate the hazard ratios (HRs) and 95% confidence intervals (95% CIs) of incident ASCVD for climbing stairs in 20-39%, 40-59%, and ≥60% compared to <20% of the time. We adjusted the regression models for age, sex, body mass index, smoking, alcohol consumption, physical activity, hypertension, diabetes, atrial fibrillation, lipid profile, chronic kidney disease, and history of cardiac murmur or valvular diseases.
RESULTS RESULTS
A total of 536 new ASCVD events were detected within a median follow-up period of 16.6 years. In the age- and sex-adjusted model, stair climbing 20-39%, 40-59%, and ≥60% of the time was associated with lower ASCVD incidence: HRs (95% CIs) = 0.72 (0.56, 0.92), 0.86 (0.68, 1.08), and 0.78 (0.61, 0.99), respectively (p-trend = 0.020). The corresponding associations were attenuated after adjusting for lifestyle and clinical factors: HRs (95% CIs) = 0.74 (0.58, 0.95), 0.90 (0.71, 1.13), and 0.89 (0.69, 1.13), respectively (p-trend = 0.152).
CONCLUSION CONCLUSIONS
Frequent stair climbing was associated with lower ASCVD incidence; however, this association was partly explained by lifestyle and clinical factors of participants.

Identifiants

pubmed: 37899207
doi: 10.1265/ehpm.23-00166
pmc: PMC10613554
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

60

Références

N Engl J Med. 2007 Jun 7;356(23):2388-98
pubmed: 17554120
Geriatr Gerontol Int. 2023 Jul;23(7):577-579
pubmed: 37317580
Environ Health Prev Med. 2023;28:26
pubmed: 37150604
Stroke. 1981 Mar-Apr;12(2 Pt 2 Suppl 1):I13-44
pubmed: 7222164
Hypertens Res. 2021 Oct;44(10):1274-1282
pubmed: 34272476
Front Psychol. 2019 Oct 15;10:2300
pubmed: 31681096
Sports (Basel). 2019 Jan 18;7(1):
pubmed: 30669254
BMC Public Health. 2021 May 14;21(1):923
pubmed: 33990186
Int J Environ Res Public Health. 2021 Jan 12;18(2):
pubmed: 33445686
J Clin Epidemiol. 1988;41(2):105-14
pubmed: 3335877
J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):298-307
pubmed: 33543604
J Am Coll Cardiol. 2020 Dec 22;76(25):2982-3021
pubmed: 33309175
Br J Sports Med. 2005 Sep;39(9):590-3
pubmed: 16118293
Environ Health Prev Med. 2022;27:10
pubmed: 35288490
Eur J Cardiovasc Prev Rehabil. 2010 Oct;17(5):569-75
pubmed: 20299999
J Vasc Surg. 2012 Jun;55(6):1662-73.e2
pubmed: 22608041
Int J Behav Nutr Phys Act. 2016 Apr 11;13:47
pubmed: 27067670
Saudi J Anaesth. 2019 Apr;13(Suppl 1):S31-S34
pubmed: 30930717
Med Sci Sports Exerc. 1997 Sep;29(9):1250-4
pubmed: 9309638
Front Sports Act Living. 2021 Feb 16;3:630912
pubmed: 33665614
Public Health. 2017 Aug;149:11-20
pubmed: 28521189
Prev Med Rep. 2019 Jun 28;15:100938
pubmed: 31338282
Environ Health Prev Med. 2022;27:23
pubmed: 35675977

Auteurs

Ahmed Arafa (A)

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center.
Department of Public Health, Faculty of Medicine, Beni-Suef University.

Rena Kashima (R)

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center.
Department of Cardiovascular Pathophysiology and Therapeutics, Graduate School of Medicine, Osaka University.

Yoshihiro Kokubo (Y)

Department of Preventive Cardiology, National Cerebral and Cardiovascular Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH